Robot surgery showdown: single port vs multi port for cancer
NCT ID NCT07610083
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will compare two types of robot-assisted surgery for prostate or kidney cancer: single-port (one small incision) and multi-port (several incisions). Researchers will track 376 adults to see which approach leads to a shorter hospital stay and better recovery. The study is observational, meaning patients are assigned to a surgery type based on medical factors, not randomly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- robot-assisted surgery (single-port vs multi-port)
- What this could lead to
- If this study shows clear benefits of one approach, it could help surgeons choose the best technique for prostate or kidney cancer patients, potentially leading to shorter hospital stays and better recovery.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be influenced by patient selection and other factors. It is early-stage evidence and may not definitively prove one method is better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Ospedale San Raffaele
Milan, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?